Two biotechnology companies are designing therapies to deliver edited genes to treat Friedreich’s ataxia and amyotrophic lateral sclerosis, or ALS. . . . → Read More: Biotechs Partner on Crispr Therapies for Neuro Disorders
|
|||||
|
       
  |
Biochemists created a polymer film derived from soy proteins in a sustainable process that can replace many of today’s single-use plastics. . . . → Read More: Plant-Based Material Designed to Replace Plastics 
Tests with lab mice show one dose of a lower cost Covid-19 vaccine given with a needle-free patch generates strong antibody and cellular immune responses. . . . → Read More: Low Cost Vaccine, Patch Device Produce Immune Responses 
Chemists at industry and academic labs created safer lipids for delivering messenger RNA vaccines, such as those protecting against Covid-19. . . . → Read More: Plant-Based Lipids Developed for mRNA Vaccines  One comment - (Comments are closed)  Joint ventures/collaborations, New products  biomedical, biotechnology, chemistry, Covid-19, engineering, Europe, life sciences, manufacturing, nanotechnology, pharmaceuticals, physical sciences, university 
Moderna Inc. and South Korea signed agreements Saturday on joint research and manufacturing opportunities for vaccines against viruses in Korea. . . . → Read More: Moderna Expands Vaccine Research, Mfring in Asia 2 comments - (Comments are closed) Joint ventures/collaborations Asia, biomedical, biotechnology, Covid-19, genomics, Japan, Korea, life sciences, manufacturing, pharmaceuticals 
A new enterprise, created by a life science venture capital company, began work on developing therapies with long-acting synthetic RNA. . . . → Read More: New Biotech Developing Synthetic Long-Term RNA 2 comments - (Comments are closed) Finance, New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, life sciences, manufacturing, pharmaceuticals, venture capital 
A company developing an automated yet personalized manufacturing platform for cell therapies is raising $82 million in its second venture funding round. . . . → Read More: Cell Therapy Mfring Company Raises $82M in Venture Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, engineering, entrepreneurs, equity, genomics, investment, life sciences, manufacturing, pharmaceuticals, physical sciences, robotics, software, venture capital 
Zymergen Inc., a developer of materials made with synthetic biology for industrial products is raising $500 million in its initial public stock offering. . . . → Read More: Biomanufacturing Materials Company Issues $500M IPO One comment - (Comments are closed) Finance agriculture, biotechnology, chemistry, economics, engineering, equity, genomics, investment, IPO, life sciences, manufacturing, materials science, mathematics, physical sciences 
Two companies with alternative techniques for manufacturing concrete won a challenge competition to convert carbon dioxide into useful products. . . . → Read More: Concrete Mfring Processes Win CO2 Conversion Challenge Comments are closed Finance, New products Canada, challenge, chemistry, cleantech, economics, energy, engineering, entrepreneurs, manufacturing, materials science, physical sciences, university 
A company with a technology it says is simpler and more like natural processes to produce synthetic DNA is raising $24 million in its first venture round. . . . → Read More: Synthetic DNA Company Raises $24M in Early Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, chemistry, engineering, entrepreneurs, equity, genomics, investment, life sciences, manufacturing, venture capital |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||